Instinctif Partners Life Sciences Team Adds Six New Clients in Q1 2015
21 April 2015, London, Manchester, Munich, New York, Sydney, Melbourne: In the first quarter of 2015, the Life Sciences team of international business communications consultancy, Instinctif Partners, had a busy kick-off to the year securing six new clients.
PR, messaging and consulting project clients include:
OccurRX is an asset spin-out from our client Fibrotech focused on ocular fibrosis. The Melbourne-based company has brought in the Instinctif Partners Australian team to support its launch release and media communications locally and internationally.
Vienna-based Themis Bioscience, a start-up company developing vaccines for infectious diseases, has engaged the German Life Sciences team to support press releases and media outreach.
Regenerys has signed up the Instinctif Partners London team to support its first press release. The regenerative medicine company works with adipose tissue for use in breast reconstruction and plastic surgery, and in skin regeneration technology.
GNA-Biosolutions is a biotech company with breakthrough laser polymerase chain reaction (PCR) technology for diagnostic purposes. GNA-Biosolutions has signed up the German Life Sciences team to support media relations.
Cardiff-based company Alesi Surgical Medical Instruments has brought in Instinctif Partners in the UK to kick-off messaging and PR planning around its new technology for clearing the surgical field of ‘surgical smoke’ during laparoscopic procedures.
Cambridge Temperature Concepts (CTC) is a MedTech company producing wearable health monitoring technology. CTC has brought in the Instinctif Partners UK team to provide consultancy around its messaging and to support media announcements in Europe, alongside work in the USA by our strategic communications partner Lazar Partners.
Website and design team projects:
The life sciences content and creative team has secured new work from our client TranScrip Partners to redesign and build its website. TranScrip is a rapidly growing, cutting-edge contract organisation that supports biopharmaceutical product development and life cycle management.
As well as PR work, Instinctif Partners provided design and web development consultancy through to implementation for CTC’s Duo Fertility website.
In addition to these new clients, Instinctif Partners also won new projects from existing clients including:
IP lawyers Marks and Clerk has returned to the fold signing up the Instinctif Partners UK team to support media communications for its annual Life Sciences Report, to be released at BIO.
Retained client Octapharma, the largest privately owned human protein products manufacturer in the world, has also tasked the UK team with a corporate sustainability project. The project is focused on its 10-year programme to successfully develop the first fully human recombinant factor VIII.
Sue Charles, Managing Partner, Instinctif Partners Life Sciences, commented “A very busy quarter and one in which we have started working with some truly exciting young companies whose technologies have great potential for the future. The briefs we have secured demonstrated our global reach and breadth of services. With many clients working across our different offices, the ability to be interconnected on a global basis is ever more important.”
For further information:
Managing Partner, Life Sciences
+44 (0)20 7457 2020
back to news